Cargando…
Efficacy and outcomes of systemic chemotherapy in posttransplant and immunosuppression associated Kaposi sarcoma: Twenty years experience of a tertiary cancer center
Kaposi sarcoma is a malignant angioproliferative disease, and human herpesvirus-8 plays a major role in its etiology. Iatrogenic Kaposi sarcoma (IKS) can occur in patients undergoing immunosuppressive therapy. The treatment strategy for patients with IKS is immunosuppressive therapy modification. Ho...
Autores principales: | Khanmammadov, Nij̇at, Paksoy, Nail, Doğan, İzzet, Ferhatoğlu, Ferhat, Saip, Pinar, Aydiner, Adnan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545387/ https://www.ncbi.nlm.nih.gov/pubmed/37773844 http://dx.doi.org/10.1097/MD.0000000000035383 |
Ejemplares similares
-
Weekly paclitaxel treatment in the first-line therapy of classic Kaposi sarcoma: A real-life study
por: Paksoy, Nail, et al.
Publicado: (2023) -
Toxicity management and efficacy of carboplatin desensitization therapy for recurrent epithelial ovarian carcinoma: A real-world study
por: Paksoy, Nail, et al.
Publicado: (2022) -
High-dose chemotherapy followed by autologous stem cell transplantation for adult patients With first relapse of Ewing’s sarcoma: A single institution experience
por: Paksoy, Nail, et al.
Publicado: (2022) -
Termination of trastuzumab in HER2-positive metastatic breast cancer patients who received trastuzumab beyond progression
por: Dogan, Izzet, et al.
Publicado: (2023) -
Evaluation of clinicopathological features determining treatment response in patients with ALK mutant NSCLC
por: Dogan, Izzet, et al.
Publicado: (2022)